Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT02704403 · TERMINATED

Trial details

NCT number: NCT02704403
Sponsor: Genfit
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Start date: 2016-03-01
Primary completion: 2020-10-28
Enrollment: 2157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.